# In-use Tolerance and Efficacy Study Under Dermatological Control of an Anti-aging Cream (Split Face) Post Facial Superficial Rejuvenation Procedures, After re Epidermization

> **NCT06942403** · NA · COMPLETED · sponsor: **Pierre Fabre Dermo Cosmetique** · enrollment: 66 (actual)

## Conditions studied

- Healthy

## Interventions

- **OTHER:** Associated product 1 : RV2666C
- **OTHER:** Associated product 2 MORNING : RV5000A
- **OTHER:** Test product : RV4983A
- **OTHER:** Associated product 2 EVENING: RV5000A

## Key facts

- **NCT ID:** NCT06942403
- **Lead sponsor:** Pierre Fabre Dermo Cosmetique
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-27
- **Primary completion:** 2024-03-26
- **Final completion:** 2024-03-26
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2025-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06942403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06942403, "In-use Tolerance and Efficacy Study Under Dermatological Control of an Anti-aging Cream (Split Face) Post Facial Superficial Rejuvenation Procedures, After re Epidermization". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06942403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*